Related Experiment Videos
Equivalent continuous clearances EKR and stdK in incremental haemodialysis
1Savonlinna Central Hospital, Dialysis Unit, Savonlinna, Finland. aarne.vartia@fimnet.fi
Summary
Residual renal function (RRF) in haemodialysis patients can replace significant dialysis time. Accounting for RRF in urea kinetic modeling improves treatment adequacy assessment and optimizes dialysis prescriptions.
Area of Science:
- Nephrology
- Renal Medicine
- Dialysis Therapy
Background:
- Residual renal function (RRF) is present in many haemodialysis patients.
- RRF is insufficient for quality of life but improves outcomes and reduces treatment burden.
- Optimal adjustment of incremental dialysis dose based on RRF remains a challenge.
Purpose of the Study:
- To investigate how residual renal function (RRF) influences the assessment of dialysis adequacy.
- To determine the impact of RRF on urea kinetic modeling parameters and treatment time.
- To evaluate the effectiveness of equivalent renal urea clearance (EKR) and standard urea clearance (stdK) in incremental dialysis.
Main Methods:
- Urea generation rate (G) and distribution volume (V) were measured using a double-pool urea kinetic model.
- Computer simulations analyzed the effect of varying RRF on EKR, stdK, and urea concentrations.
- Calculated required treatment times to meet HEMO study standard dose equivalent targets.
Main Results:
- Ignoring RRF leads to underestimation of key parameters like EKR, stdK, and urea generation rate.
- Both EKR and stdK showed a linear increase with increasing renal urea clearance (Kr).
- RRF can significantly reduce the required weekly dialysis treatment time to achieve standard dose targets, with stdK reflecting RRF more than EKR.
Conclusions:
- EKR and stdK, when determined by kinetic modeling, are effective measures for assessing dialysis adequacy in incremental dialysis.
- Incorporating RRF into EKR and stdK calculations provides a more accurate picture of dialysis effectiveness.
- Incremental dialysis strategies can leverage RRF to optimize treatment duration and patient outcomes.
Related Concept Videos
01:24Hemodialysis II: Procedure and Complications
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
01:25Hemodialysis I: Introduction
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
01:30Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
01:25Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...